Your browser doesn't support javascript.
loading
Effect of Tablet-based Cognitive Intervention on Cognition in Patients With Mild Cognitive Impairment: A Pilot Study.
Park, Ji Young; Choi, Seon Ae; Kim, Jae Joon; Park, Yu Jeong; Kim, Chi Kyung; Cho, Geum Joon; Koh, Seong-Beom; Kang, Sung Hoon.
Afiliação
  • Park JY; Geumcheon Center for Dementia, Seoul, Korea.
  • Choi SA; Geumcheon Center for Dementia, Seoul, Korea.
  • Kim JJ; Geumcheon Center for Dementia, Seoul, Korea.
  • Park YJ; Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
  • Kim CK; Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
  • Cho GJ; Department of Obstetrics and Gynecology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
  • Koh SB; Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
  • Kang SH; Geumcheon Center for Dementia, Seoul, Korea.
Dement Neurocogn Disord ; 22(4): 130-138, 2023 Oct.
Article em En | MEDLINE | ID: mdl-38025410
Background and Purpose: Growing evidence has shown that cognitive interventions can mitigate cognitive decline in patients with mild cognitive impairment (MCI). However, most previous cognitive interventions have been group-based programs. Due to their intrinsic limitations, group-based programs are not widely used in clinical practice. Therefore, we have developed a tablet-based cognitive intervention program. This preliminary study investigated the feasibility and effects of a 12-week structured tablet-based program on cognitive function in patients with MCI. Methods: We performed a single-arm study on 24 patients with MCI. The participants underwent a tablet-based cognitive intervention program 5 times a week over a 12-week period. The primary outcome was changes in cognitive function, measured using the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K). Outcomes were evaluated at baseline, within two weeks of the last program (post-intervention), and at the six-month follow-up session. Results: The completion rate of the tablet-based program was 83.3% in patients with MCI. The program improved cognitive function based on the CERAD-K total score (p=0.026), which was maintained for at least three months (p=0.004). There was also an improvement in the depression scale score (p=0.002), which persisted for three months (p=0.027). Conclusions: Our 12-week structured tablet-based program is feasible for patients with MCI. Furthermore, although further studies with a double-arm design are required, the program appears to be an effective strategy to prevent cognitive decline in patients with MCI.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article